Clinical Trial

Phase II Trial of RC1416 Injection in Asthma

Name: Phase II Trial of RC1416 Injection in Asthma — clinical trial record (NCT07403487)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a phase II study of RC1416 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of RC1416 in subjects with severe uncontrolled asthma.

Trial Details

NCT Number	NCT07403487
Lead Sponsor	Nanjing RegeneCore Biotech Co., Ltd.
Conditions	Moderate to Severe Asthma
Enrollment	195 participants
Start Date	2026-03-10
Primary Completion	2027-10-25 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-02-11